50
Participants
Start Date
October 23, 2018
Primary Completion Date
May 15, 2020
Study Completion Date
May 15, 2020
BPZE1
Lyophilized, live-attenuated Bordetella pertussis vaccine reconstituted with sterile water for injection (SWFI) and administered as a single intranasal dose of either 10\^7 colony forming units (CFU) or 10\^9 CFU.
Placebo
The placebo consists of the same constituents in the same quantities as the BPZE1 investigational vaccines, absent the attenuated B. pertussis cells, reconstituted with sterile water for injection (SWFI).
Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville
National Institute of Allergy and Infectious Diseases (NIAID)
NIH